Steve Woolfenden

983 citations

12 papers · 714 indexed · h-index 8

Impact in

Cancer Research top 10%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Genetics top 10%
- Glioma Diagnosis and Treatment

Papers in

Genetics 5
- Glioma Diagnosis and Treatment 4
- Chronic Lymphocytic Leukemia Research 1
Molecular Biology 9
- PI3K/AKT/mTOR signaling in cancer 2
- Cancer-related gene regulation 2
- bioluminescence and chemiluminescence research 1

Co-authors: Al Charest Roderick T. Bronson Haihao Zhu Ronald A. Meyer Margaret E. McLaughlin David E. Housman Joseph D. Growney Mindy H. Hsieh
Journals: Proceedings of the National Academy of Sciences (3 papers)Cancer Research (3 papers)Molecular Cancer Therapeutics (1 paper)Endocrinology (1 paper)genesis (1 paper)
Partner nations: United States France

In The Last Decade

Steve Woolfenden

12 papers receiving 702 citations

Peers

Countries citing papers authored by Steve Woolfenden

Since Specialization

Citations

This map shows the geographic impact of Steve Woolfenden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Woolfenden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Woolfenden more than expected).

Fields of papers citing papers by Steve Woolfenden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Woolfenden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Woolfenden. The network helps show where Steve Woolfenden may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steve Woolfenden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steve Woolfenden Line = papers co-authored together Steve Woolfenden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	Model‐based dose selection to inform translational clinical oncology development of WNT974, a first‐in‐class Porcupine inhibitor Clinical and Translational Science ·Yan Ji, Salim Nurul F., Steve Woolfenden, Andrea P. Myers	2022	7
2	A Novel Antibody-Drug Conjugate Targeting CCR7 in Hematologic Malignancies Blood ·Lucy Krebs, Deborah Knee, Chhabi Seth -, Feng Gao, Heorhii Potulnytskyi, Manjari P., Samual C. Perez, S. MUTTAMARA, Keith G. Mansfield, May Liu, 雅惠, Emily K. Meseck, Steve Woolfenden, Sean G. Buchanan, David P. Steensma, Vasileios Askoxylakis	2022	4
3	Abstract 2140: Dual Wnt and EGFR-MAPK dependency of BRAFV600E-mutant colorectal cancer Cancer Research ·Youzhen Wang, Michael R. Palmer, Savina Jaeger, Gallayanee Parkatt, Shumei Qiu, Steve Woolfenden, Ronald A. Meyer, Guizhi Yang, John Green, Shifeng Pan, Jun Liu, Hui Gao, Z. Alexander Cao, Andrea P. Myers, Margaret E. McLaughlin	2015	3
4	ROS1 Signaling Regulates Epithelial Differentiation in the Epididymis Endocrinology ·Hyun Jung Jun, Jeremy Roy, Tegan Smith, Levi B. Wood, Keara Lane, Steve Woolfenden, М. К. Кароли, Roderick T. Bronson, Kevin M. Haigis, Sylvie Breton, Al Charest	2014	29
5	Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma Proceedings of the National Academy of Sciences ·Xiaomo Jiang, Huai-Xiang Hao, Joseph D. Growney, Steve Woolfenden, Sahala Firdaus Syah Doloksaribu, Nicholas Ng, Bo Lü, Mindy H. Hsieh, Gallayanee Parkatt, Ronald A. Meyer, Timothy R. Smith, 苟駿, Olga Charlat, Yang Xie, Jeffery A. Porter, Shifeng Pan, Jun Liu, Margaret E. McLaughlin, Feng Cong	2013	325
6	Chronic Activation of Wild-Type Epidermal Growth Factor Receptor and Loss of Cdkn2a Cause Mouse Glioblastoma Formation Cancer Research ·Jaime Acquaviva, Blaise Kelly, Julie Lessard, Natalia Reyes Ríos, Huijun Zhu, Michael Donovan, Steve Woolfenden, Abraham Boskovitz, Ami P. Raval, Rod T. Bronson, Rolf Pfannl, Charles A. Whittaker, David E. Housman, Alain Charest	2011	1
7	Acquired MET expression confers resistance to EGFR inhibition in a mouse model of glioblastoma multiforme Oncogene ·Hyun Jung Jun, Jaime Acquaviva, Infante Toro, Julie Lessard, Haihao Zhu, Steve Woolfenden, Roderick T. Bronson, Rolf Pfannl, (unknown), (unknown), Lakshmanan K. Iyer, (unknown), (unknown), Ami P. Raval, Alain Charest	2011	8
8	Maintenance of adenomatous polyposis coli ( APC )-mutant colorectal cancer is dependent on Wnt/β-catenin signaling Proceedings of the National Academy of Sciences ·Alix Scholer‐Dahirel, Michael R. Schlabach, Alice Loo, Gallayanee Parkatt, Ronald A. Meyer, Ribo Guo, Steve Woolfenden, Kristine Yu, Judit Markovits, Xin Qiongzh, Dmitriy Sonkin, Yung‐Mae Yao, Markus Warmuth, William R. Sellers, Robert Schlegel, Frank Stegmeier, Rebecca Mosher, Margaret E. McLaughlin	2011	85
9	The Novel Hsp90 Inhibitor NXD30001 Induces Tumor Regression in a Genetically Engineered Mouse Model of Glioblastoma Multiforme Molecular Cancer Therapeutics ·Haihao Zhu, Steve Woolfenden, Roderick T. Bronson, Zahara M. Jaffer, Sofía Barluenga, Nicolas Winssinger, Allan E. Rubenstein, Ruihong Chen, Al Charest	2010	28
10	Epigenetic Regulation of c-ROS Receptor Tyrosine Kinase Expression in Malignant Gliomas Cancer Research ·Hyun Jung Jun, Steve Woolfenden, 真一佐沢, Keara Lane, Roderick T. Bronson, David E. Housman, Ж.А. Карабаев	2009	36
11	A Cre/LoxP conditional luciferase reporter transgenic mouse for bioluminescence monitoring of tumorigenesis genesis ·Steve Woolfenden, Haihao Zhu, Al Charest	2009	16
12	Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis Proceedings of the National Academy of Sciences ·Haihao Zhu, Jaime Acquaviva, V P Romenskiĭ, Abraham Boskovitz, Steve Woolfenden, Rolf Pfannl, Roderick T. Bronson, John W. Chen, Ralph Weissleder, David E. Housman, Al Charest	2009	172

About Steve Woolfenden

Steve Woolfenden is a scholar working on Genetics, Molecular Biology, Hepatology, Statistics and Probability and Reproductive Medicine, having authored 12 papers that have together received 714 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (4 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer-related gene regulation (2 papers), Cancer Mechanisms and Therapy (1 paper), Cancer Research and Treatments (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and bioluminescence and chemiluminescence research (1 paper). The work is most often cited by research in Cancer Research (178 citations), Genetics (117 citations), Oncology (248 citations), Molecular Biology (491 citations) and Pathology and Forensic Medicine (68 citations). Steve Woolfenden has collaborated with scholars based in United States and France. Frequent co-authors include Al Charest, Roderick T. Bronson, Haihao Zhu, Ronald A. Meyer, Margaret E. McLaughlin, David E. Housman, Joseph D. Growney, Mindy H. Hsieh, Feng Cong and Shifeng Pan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research, Molecular Cancer Therapeutics, Endocrinology and genesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact